Ivabradine Monosulfate Sustained-release Tablets(Jiangsu Hengrui Medicine)

硫酸氢伊伐布雷定缓释片(江苏恒瑞医药)

Report date: 2025/08/15 16:11:49

Base Information

Drug NameIvabradine Monosulfate Sustained-release Tablets(Jiangsu Hengrui Medicine)
Drug Alias Name硫酸伊伐布雷定硫酸伊伐雷定
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHyperpolarization-activated cyclic nucleotide-gated channel blockers
TargetsHyperpolarization-activated cyclic nucleotide-gated channel
Therapy Area/IndicationsAngina, StableAngina PectorisHeart Failure
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsAngina, StableAngina PectorisHeart Failure

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBank